Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

8.770
-0.330-3.63%
Volume:150.35M
Turnover:1.32B
Market Cap:101.05B
PE:22.07
High:9.090
Open:8.900
Low:8.705
Close:9.100
52wk High:10.943
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:1.39
T/O Rate:1.30%
Dividend:0.34
Dividend Rate:3.85%
EPS(LYR):0.397
ROE:20.90%
ROA:10.70%
PB:2.30
PE(LYR):22.07
PS:2.76

Loading ...

CSPC Pharmaceutical Group Stock Slips 3.6% in Hong Kong, Underperforms Competitors

Dow Jones
·
1 hour ago

Global Equities Roundup: Market Talk

Dow Jones
·
2 hours ago

Hong Kong Market Flash | CSPC Pharma Drops Over 4% as Lp(a) HORIZON Study Setback May Pressure Participants Including the Company

Stock News
·
3 hours ago

CSPC Pharma's Clinical Data Presentations Could be Near-Term Share Catalysts

Dow Jones
·
3 hours ago

Movement Alert|CSPC PHARMA Falls 3.3% in Regular Trading, Pharma Sector Under Broad Selling Pressure Amid Global Risk-Off

Market Focus
·
7 hours ago

CSPC Pharma Gets Clinical Trial Nod in China for Solid Tumors Drug

MT Newswires Live
·
Yesterday

CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval in China

Reuters
·
Yesterday

CSPC PHARMA Wins NMPA Approval to Start Clinical Trial for First Long-Acting Subcutaneous Rotigotine Injection

Bulletin Express
·
Yesterday

CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China

Stock News
·
Yesterday

CSPC Pharma Gains Chinese Clinical Trial Approval for Goserelin Extended-Release Injection

Stock News
·
Yesterday

CSPC Pharma Wins China Clinical Trial Clearance for Syh9102 Goserelin Injection

Reuters
·
Yesterday

CSPC Pharmaceutical - Goserelin Sustained-Release Injection (Syh9102 Injection) Obtains Clinical Trial Approval in China

THOMSON REUTERS
·
Yesterday

Movement Alert|CSPC PHARMA Falls 3.03% in Regular Trading, Global Market Selloff Drags Down Pharmaceutical Sector

Market Focus
·
Yesterday

CSPC Pharmaceutical Gets China Approval for Eye Drug Clinical Trials

MT Newswires Live
·
Sep 08

CSPC Wins China Clinical Trial Approval for Syh2083 Dry Eye Drops

Reuters
·
Sep 08

CSPC Pharmaceutical - Syh2083 Eye Drops Obtain Clinical Trial Approval in China

THOMSON REUTERS
·
Sep 08

CSPC Pharmaceutical Group Stock Falls 2.7% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 08

Market Bets on BOJ Rate Hike While CICC's Merger Wins Regulatory Approval

Stock News
·
Sep 08

CSPC Pharma Begins Phase II Study of Influenza Drug in China

MT Newswires Live
·
Sep 07

Fourth Breakthrough Therapy Designation Granted to EGFR-Targeted ADC Developed by CSPC

Deep News
·
Sep 07